Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Jan;39(1):268–270. doi: 10.1128/aac.39.1.268

Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp.

C von Eiff 1, M Herrmann 1, G Peters 1
PMCID: PMC162524  PMID: 7695321

Abstract

The in vitro susceptibilities of 63 isolates of Stomatococcus mucilaginosus and of 188 isolates of Micrococcus spp. to 18 antimicrobial agents were determined by the agar dilution method. Many beta-lactams, imipenem, rifampin, and the glycopeptides were shown to be active in vitro against Stomatococcus and Micrococcus isolates, whereas the activities of antibiotics such as some aminoglycosides, erythromycin, and fosfomycin against an important number of these microorganisms are limited.

Full Text

The Full Text of this article is available as a PDF (173.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adang R. P., Schouten H. C., van Tiel F. H., Blijham G. H. Pneumonia due to Micrococcus spp. in a patient with acute myeloid leukaemia. Leukemia. 1992 Mar;6(3):224–226. [PubMed] [Google Scholar]
  2. Ascher D. P., Zbick C., White C., Fischer G. W. Infections due to Stomatococcus mucilaginosus: 10 cases and review. Rev Infect Dis. 1991 Nov-Dec;13(6):1048–1052. doi: 10.1093/clinids/13.6.1048. [DOI] [PubMed] [Google Scholar]
  3. Chomarat M., Martin C., Breysse F. Sensibilité aux antibiotiques de trente-deux souches de Stomatococcus mucilaginosus chez des patients de stomatologie en pratique de ville. Pathol Biol (Paris) 1989 May;37(5):378–381. [PubMed] [Google Scholar]
  4. Chomarat M., Vital M. G., Flandrois J. P. Susceptibility to aminoglycosides of 63 strains of Stomatococcus mucilaginosus isolated from sputum. Zentralbl Bakteriol. 1991 Dec;276(1):63–67. doi: 10.1016/s0934-8840(11)80219-7. [DOI] [PubMed] [Google Scholar]
  5. Gahrn-Hansen B., Heltberg O., Rosdahl V. T., Søgaard P. Evaluation of a conventional routine method for identification of clinical isolates of coagulase-negative Staphylococcus and Micrococcus species. Comparison with API-Staph and API-Staph-Ident. Acta Pathol Microbiol Immunol Scand B. 1987 Oct;95(5):283–292. doi: 10.1111/j.1699-0463.1987.tb03126.x. [DOI] [PubMed] [Google Scholar]
  6. Hansen B. G. Etiologic importance of coagulase-negative Micrococcaceae isolated from blood cultures. Acta Pathol Microbiol Immunol Scand B. 1985 Feb;93(1):1–6. doi: 10.1111/j.1699-0463.1985.tb02843.x. [DOI] [PubMed] [Google Scholar]
  7. Henwick S., Koehler M., Patrick C. C. Complications of bacteremia due to Stomatococcus mucilaginosus in neutropenic children. Clin Infect Dis. 1993 Oct;17(4):667–671. doi: 10.1093/clinids/17.4.667. [DOI] [PubMed] [Google Scholar]
  8. Kaufhold A., Reinert R. R., Kern W. Bacteremia caused by Stomatococcus mucilaginosus: report of seven cases and review of the literature. Infection. 1992 Jul-Aug;20(4):213–220. doi: 10.1007/BF02033062. [DOI] [PubMed] [Google Scholar]
  9. Kim E. L., Ching D. L., Pien F. D. Bacterial endocarditis at a small community hospital. Am J Med Sci. 1990 Feb;299(2):87–93. doi: 10.1097/00000441-199002000-00002. [DOI] [PubMed] [Google Scholar]
  10. Magee J. T., Burnett I. A., Hindmarch J. M., Spencer R. C. Micrococcus and Stomatococcus spp. from human infections. J Hosp Infect. 1990 Jul;16(1):67–73. doi: 10.1016/0195-6701(90)90050-x. [DOI] [PubMed] [Google Scholar]
  11. McWhinney P. H., Kibbler C. C., Gillespie S. H., Patel S., Morrison D., Hoffbrand A. V., Prentice H. G. Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. Clin Infect Dis. 1992 Mar;14(3):641–646. doi: 10.1093/clinids/14.3.641. [DOI] [PubMed] [Google Scholar]
  12. Pinsky R. L., Piscitelli V., Patterson J. E. Endocarditis caused by relatively penicillin-resistant Stomatococcus mucilaginosus. J Clin Microbiol. 1989 Jan;27(1):215–216. doi: 10.1128/jcm.27.1.215-216.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rhoden D. L., Hancock G. A., Miller J. M. Numerical approach to reference identification of Staphylococcus, Stomatococcus, and Micrococcus spp. J Clin Microbiol. 1993 Mar;31(3):490–493. doi: 10.1128/jcm.31.3.490-493.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rochette A., Chomarat M., de Montclos M. Sensibilité aux antibiotiques de soixante-quatre souches de Stomatococcus mucilaginosus isolées en clinique humaine. Mise en évidence d'une résistance à l'érythromycine. Pathol Biol (Paris) 1988 May;36(5):394–397. [PubMed] [Google Scholar]
  15. Selladurai B. M., Sivakumaran S., Aiyar S., Mohamad A. R. Intracranial suppuration caused by Micrococcus luteus. Br J Neurosurg. 1993;7(2):205–207. doi: 10.3109/02688699309103481. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES